News
OCS-Sparing Effect of Dupilumab for Severe Asthma Maintained
Oral corticosteroid dosage reduction sustained in open-label extension study of dupilumab
Oral corticosteroid dosage reduction sustained in open-label extension study of dupilumab
Drug-induced immunosuppression, particularly from oral corticosteroids, may limit response to COVID-19 vaccine
Patients with flares more likely to have inpatient, emergency department visits